Abstract 16374: Effect of Dapagliflozin According to Duration of Heart Failure: An Analysis of the DAPA-HF Trial

Su E. Yeoh,Kieran F. Docherty,Silvio E. Inzucchi,Lars Køber,Mikhail Kosiborod,Anna Maria Langkilde,Feilpe A Martinez,Olof Bengtsson,Piotr Ponikowski,Marc S. Sabatine,Mikaela SjÃ¶strand,Scott D. Solomon,Pardeep S. Jhund,John J.V. McMurray

Abstract 16374: Effect of Dapagliflozin According to Duration of Heart Failure: An Analysis of the DAPA-HF Trial

2020

Su E. Yeoh
Kieran F. Docherty
Silvio E. Inzucchi
Lars Køber
Mikhail Kosiborod
Anna Maria Langkilde
Feilpe A Martinez
Olof Bengtsson
Piotr Ponikowski
Marc S. Sabatine
Mikaela SjÃ¶strand
Scott D. Solomon
Pardeep S. Jhund
John J.V. McMurray

Introduction: The relationship between duration of heart failure (HF), patient characteristics, outcomes, and the effect of treatment is largely unknown. We investigated these questions in DAPA-HF....

Keywords:

patient characteristics
Diabetes type ii
Heart failure
Cardiology
Internal medicine
Medicine
Dapagliflozin
Clinical trial

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations